PhaseRx's Convertible Note - III Round

PhaseRx raised a round of funding on October 02, 2013.

PhaseRx is an RNAi delivery technology company developing a polymer-based system that enables the systemic delivery of RNAi-based drugs and potentially other macromolecules as therapeutic products. Th…

Articles about PhaseRx's Convertible Note - III Round: